Join to View Full Profile
1364 Clifton Road NE, Room H184Atlanta, GA 30322
Phone+1 404-712-8579
Dr. Badve is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1998
Grant Medical CollegeClass of 1986
Certifications & Licensure
GA State Medical License 2021 - 2026
IN State Medical License 2002 - 2021
IL State Medical License 1999 - 2002
NY State Medical License 1999 - 2000
CT State Medical License 1998 - 1999
American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Start of enrollment: 2009 Apr 01
- Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) Start of enrollment: 2019 Dec 10
- Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease Start of enrollment: 2020 Dec 14
Publications & Presentations
PubMed
- HER2 testing in multiple solid tumor types: concordance of immunohistochemistry scores between three HER2 scoring algorithms.Sunil S Badve, Michelle Shiller, Wentao Yang, Helen Bridge, Adam Brown
Virchows Archiv. 2026-02-11 - Thymic Rosai-Dorfman Disease: A Rare Presentation With Unusual Histopathologic Features.Ahmed I Younes, Tiffany Javadi, Megan Dibbern, Sunil Badve
International Journal of Surgical Pathology. 2026-02-01 - Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer.Aynura Mammadova, Yuan Gu, Ling Ruan, Sunil S Badve, Yesim Gökmen-Polar
Biomolecules. 2026-01-06
Journal Articles
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerMatthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine
Press Mentions
Cardiovascular Risk Factors Play Greater Role in Adverse Outcomes in Thymic Cancer PatientsFebruary 25th, 2025- Managing Central Nervous System Metastasis in Patients with HER2-Positive Breast CancerOctober 22nd, 2024
- Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
